EBSCO Logo
Connecting you to content on EBSCOhost
Title

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Authors

Dinić, Jelena; Jovanović Stojanov, Sofija; Dragoj, Miodrag; Grozdanić, Marija; Podolski-Renić, Ana; Pešić, Milica

Abstract

The field of oncology has witnessed remarkable progress in personalized cancer therapy. Functional precision medicine has emerged as a promising avenue for achieving superior treatment outcomes by integrating omics profiling and sensitivity testing of patient-derived cancer cells. This review paper provides an in-depth analysis of the evolution of cancer-directed drugs, resistance mechanisms, and the role of functional precision medicine platforms in revolutionizing individualized treatment strategies. Using two-dimensional (2D) and three-dimensional (3D) cell cultures, patient-derived xenograft (PDX) models, and advanced functional assays has significantly improved our understanding of tumor behavior and drug response. This progress will lead to identifying more effective treatments for more patients. Considering the limited eligibility of patients based on a genome-targeted approach for receiving targeted therapy, functional precision medicine provides unprecedented opportunities for customizing medical interventions according to individual patient traits and individual drug responses. This review delineates the current landscape, explores limitations, and presents future perspectives to inspire ongoing advancements in functional precision medicine for personalized cancer therapy.

Subjects

INDIVIDUALIZED medicine; ANTINEOPLASTIC agents; CANCER treatment; TREATMENT effectiveness; DRUG resistance; CELL culture

Publication

Life (2075-1729), 2024, Vol 14, Issue 9, p1142

ISSN

2075-1729

Publication type

Academic Journal

DOI

10.3390/life14091142

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved